Orasure Technologies Receives FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test

Go back to Orasure Technologies Receives FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test
OraSure Technologies, Inc. (NASDAQ: OSUR) Delayed: 4.22 +0.06 (1.44%)
Previous Close $4.16    52 Week High $9.05 
Open $4.12    52 Week Low $5.10 
Day High $4.27    P/E N/A 
Day Low $4.11    EPS $-0.20 
Volume 271,526